About RLS Therapeutics

About company

RLS Therapeutics is creating a novel small molecule therapeutic to treat a wide spectrum of disease states rooted in inflammation and cellular dysfunction processes in both animals and humans. Strong and compelling anecdotal data has led to the creation of several variants of the lead molecule. Our current lead drug candidate is focused on the treatment of neurodegenerative disease.